The Democratic Republic of the Congo (DRC) has begun implementing HIV self-testing to boost the first "95" of the UNAIDS 95-95-95 targets by 2025. This study aims to assess the performance and usability of the Exacto Test HIV (Biosynex, Strasbourg, France) self-test in the lab and in the field. The Exacto Test HIV self-test demonstrated high virological performance (sensitivity, 99.6%; specificity, 100%) in the lab and in the field in the hand of untrained users (sensitivity, 100%; specificity, 98.9%). Taken together, the excellent performance and usability characteristics of the Exacto Test HIV (Biosynex) selftest make the kit a viable option for HIV self-testing in the DRC.
CITATION STYLE
Tonen-Wolyec, S., Masidi, J. M., Lukusa, L. F. K., Dikumbwa, G. N., Sarassoro, A., & Bélec, L. (2020). Analytical Performance of the Exacto Test HIV Self-Test: A Cross-Sectional Field Study in the Democratic Republic of the Congo. Open Forum Infectious Diseases, 7(12). https://doi.org/10.1093/ofid/ofaa554
Mendeley helps you to discover research relevant for your work.